Cadence Pharmaceuticals

About:

Cadence Pharmaceuticals is a manufactures of medicines , especially pain management solutions.

Website: http://www.cadencepharm.com

Top Investors: New Enterprise Associates, Venrock, Versant Ventures, Frazier Healthcare Partners, Domain Associates

Description:

Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. On May 4, 2010 Cadence resubmitted a New Drug Application for its investigational product candidate, OFIRMEVTM (acetaminophen) injection for the treatment of pain and fever in adults and children. The FDA has assigned a new Prescription Drug User Fee Act (PDUFA) action date for OFIRMEV of November 4, 2010.

Total Funding Amount:

$86.6M

Headquarters Location:

San Diego, California, United States

Founded Date:

2004-01-01

Contact Email:

info(AT)cadencepharm.com

Founders:

Ted Schroeder

Number of Employees:

251-500

Last Funding Date:

2009-02-23

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai